Menu

L-Carnosine

Also known as: Carnosine, Beta-alanyl-L-histidine

A muscle dipeptide sold for metabolic and healthy-aging goals, with mixed small-trial evidence.

Fine pale powder beside folded red athletic fabric and glassware
Editorial illustration

Carnosine is a dipeptide made from beta-alanine and histidine and concentrated in skeletal muscle. Supplemental carnosine has been studied for glucose control, body composition, and oxidative stress, but reviews find small, heterogeneous trials. It is not the same as beta-alanine, which raises muscle carnosine through a different intervention.2, 3

  • A dipeptide rather than a single amino acid1, 2
  • Naturally concentrated in muscle1, 2
  • Rapidly broken down by serum carnosinase1, 2
  • Clinical outcomes remain uncertain1, 2

What is L-Carnosine?

Carnosine buffers acidity and participates in reactions with reactive carbonyl compounds in laboratory systems. Whether oral dosing produces meaningful clinical effects depends on digestion, carnosinase activity, tissue delivery, and the population studied.1, 2

Where it comes from

Natural sources

  • Skeletal muscle of humans and animals
  • Meat and fish

How it's made

Supplemental L-carnosine is manufactured or produced enzymatically and purified.

What it does in products

  • Dipeptide supplement
  • Healthy-aging formula
  • Metabolic-support formula

Benefits

Glucose and metabolic markers

limited evidence

Meta-analyses suggest possible changes in selected glycemic measures, but confidence is limited by small heterogeneous trials.3

Populations, doses, co-interventions, and endpoints vary; evidence does not establish diabetes treatment.

Weight and central-obesity markers

limited evidence

A meta-analysis reported possible changes in body-size and metabolic measures with histidine-containing dipeptides.3

The analysis pooled small trials of related compounds and does not establish durable weight-loss benefit from carnosine alone.

Evidence scope and limitations

Oral intact carnosine is distinguished from beta-alanine and carnosine analog medicines.

  • Trials are generally small and heterogeneous.
  • Biomarker changes do not establish long-term clinical benefit.

Evidence last checked: 2026-09-28

Side effects & safety

Digestive discomfort or headache (uncommon)Short trials generally report few events, but long-term safety data are limited.

Safety considerations

  • Avoid supplemental doses during pregnancy or breastfeeding unless advised by a clinician.
  • Diabetes medicines, because glucose markers may change
  • Not for: Replacing established diabetes or neurologic care
2

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In supplement studies and products

Trials commonly use several hundred milligrams to about 2 g daily for weeks or months; these are research ranges, not a personal prescription.

2, 3

Regulatory status

  • Sold as a dietary supplement and not FDA-approved for diabetes, cognitive decline, or anti-aging treatment.
4

Do not borrow beta-alanine outcomes

Beta-alanine is a precursor used to increase intramuscular carnosine and has a distinct sports-performance literature. A beta-alanine trial does not directly prove the effect of swallowing intact carnosine.

1, 2

Frequently asked questions

Is carnosine the same as carnitine?

No. They are different molecules with different metabolic roles.2, 3

Is carnosine the same as beta-alanine?

No. Beta-alanine is one of its building blocks and has a separate evidence base.2, 3

The bottom line

Carnosine biology is plausible, but present human trials do not justify broad metabolic, weight-loss, or longevity promises.

References

  1. Carnosine: compound summary. PubChem, National Library of Medicine (2026) · ingredient monograph · CID 439224
  2. Effect of carnosine or β-alanine supplementation on markers of glycemic control and insulin resistance in humans and animals: a systematic review and meta-analysis. Advances in Nutrition (2021) · meta analysis · PMID 34333586
  3. Histidine-containing dipeptides reduce central obesity and improve glycaemic outcomes: a systematic review and meta-analysis of randomized controlled trials. Obesity Reviews (2020) · meta analysis · PMID 31828942
  4. Dietary Supplements. U.S. Food and Drug Administration (2025) · government guidance

Revision history

  1. Initial publication with claim-level citations, formulation limits, safety context, and editorial evidence review.